Menu
Menu
Explore our FAQ’s to gain insights into the Neoshape Semaglutide Treatment. Here, we cover everything from how the treatment works to what you can expect along your journey. Our goal is to provide clarity and confidence as you take the next steps toward achieving your wellness goals.
Semaglutide is a medication primarily used to treat type 2 diabetes and, more recently, for weight management in certain individuals.
It’s a glucagon-like peptide-1 (GLP-1) receptor agonist, which means it mimics a hormone that helps regulate blood sugar levels by stimulating insulin secretion, reducing glucagon release, and slowing gastric emptying. This leads to improved blood sugar control and can help with weight loss by promoting a feeling of fullness.
Tirzepatide is a medication used to treat type 2 diabetes and assist with weight management. It combines the effects of two hormones, GLP-1 and GIP, to improve blood sugar control and support significant weight loss.
Tirzepatide works by mimicking two natural hormones—GLP-1 and GIP—helping to stimulate insulin production, reduce glucagon release, and promote satiety, which results in better blood sugar control and enhanced weight loss.
This all depends on how your physiology responds to the therapy, and provided you focus on high-protein meals, minimizing processed foods, and exercise. You can expect to lose about 5-10% of your body weight.
You don’t need to partake in intense, regular exercise in order to see results when using Semaglutide. We recommend moderate exercise 3-4 times a week, prioritizing resistance exercise.
Tirzepatide works by mimicking two natural hormones—GLP-1 and GIP—helping to stimulate insulin production, reduce glucagon release, and promote satiety, which results in better blood sugar control and enhanced weight loss.
Clinical studies have shown that patients using Tirzepatide can lose 15-20% of their body weight, especially when combined with a healthy diet and moderate exercise.
Similar to Semaglutide, common side effects of Tirzepatide include nausea, diarrhea, and stomach discomfort. These usually diminish as your body adjusts to the medication.
Yes, it’s important to discuss all medications and previous treatments with your doctor before starting Semaglutide, as they can assess your suitability for the medication.
No, current research does not indicate that Semaglutide directly causes fertility issues. Most studies focus on its effects on blood sugar control, weight management, and potential side effects.
It’s generally advisable to limit alcohol consumption while taking Semaglutide, as alcohol can affect blood sugar levels and may increase the risk of gastrointestinal side effects, such as nausea or vomiting.
Yes, Tirzepatide is considered safe for long-term use when monitored by your healthcare provider. Ongoing management of side effects and blood sugar levels is important to ensure its effectiveness and safety.
While moderate alcohol consumption may be possible for some users, it’s essential to monitor your blood sugar levels and discuss alcohol use with your healthcare provider to avoid complications.
Tirzepatide is not recommended during pregnancy, as there may be potential risks to the developing fetus. If you are pregnant or planning to become pregnant, consult your doctor before starting this medication.
Whether you need to stay on Semaglutide long-term depends on your individual health goals and circumstances.
Yes, it is considered safe for long-term use for many individuals, especially when monitored by your doctor.
Clinical studies have shown that Semaglutide can lead to significant weight loss, often more than many other weight loss medications. In some trials, participants lost around 15-20% of their body weight.
